Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine. | Dermatol Ther;35(3): e15280, 2022 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine.

Okan, Gokhan; Vural, Pervin.

Okan G; Memorial Bahcelievler Hospital, Istanbul, Turkey.
Vural P; Department of Biochemistry, Istanbul University, Istanbul, Turkey.

Dermatol Ther ; 35(3): e15280, 2022 Mar.

Article in English | MEDLINE | ID: covidwho-1583587

Subject(s)

COVID-19; Vitiligo; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; RNA, Messenger; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitiligo / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15280

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitiligo / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15280